Goodman et al., with an analysis of 21 types of cancer, including gastrointestinal tumors (n = 151), showed that TMB was significantly associated with the ORR and survival prognosis of PD-1/PD-L1 inhibitors. This evidence concerns the gene CD274 and cancer.